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Background: Despite high levels of clinically significant persistent cancer related fatigue in breast cancer survivors
few treatments are currently available and most pose a significant burden on the part of the woman. Acupressure,
a component of Traditional Chinese Medicine, has been shown to decrease fatigue levels by as much as 70% in
cancer survivors while being inexpensive, non-toxic and an easy to use intervention. The primary aim of this study
was to determine the efficacy of two types of self-administered acupressure (relaxation acupressure and stimulating
acupressure), compared to standard of care on fatigue severity. Secondary aims were to evaluate the efficacy of
two types of acupressure on sleep and kinetic parameters required for implementation of acupressure in a clinical
setting; The purpose of this paper is to share the methodology used including challenges and insights.
Methods/design: This study is a three group, randomized clinical trial. 375 breast cancer survivors at least
12 months after completion of cancer treatments, with moderate to severe persistent fatigue, are being
randomized to one of 3 groups: self-administered relaxation acupressure; self-administered stimulating acupressure;
or standard of care. Participants are assessed at baseline, 3 weeks, and 6 weeks followed by a 4-week follow-up
period. The primary aim is to examine the effect of 6-weeks of relaxation acupressure compared to stimulatory
acupressure or standard of care on fatigue as assessed by: weekly self-report using the Brief Fatigue Inventory;
objective daytime physical activity on actigraph; or fatigue patterns assessed 4-times daily using a visual analog
scale. Secondary endpoints include depression, anxiety, self-efficacy, and sleep quality.
Discussion: This study has the potential to develop a low-cost, self-care intervention for the most troubling of
late-term effects in breast cancer populations, fatigue. The methods used may lend constructive ideas to other
investigators working with this population and/or intervention.
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There are nearly 3 million breast cancer survivors in
the US [1]. Persistent cancer-related fatigue (PCRF) is
one of the most distressing symptoms experienced by
breast cancer (BC) survivors [2,3]. Rates of PCRF in BC
survivors range from 30% to 82% and persist for as long
as 10 years after diagnosis [3-7]. PCRF is associated with
decreased quality of life, [5,6,8] and decreased sleep
quality [5,6]. Beyond poor quality of life, subjective
reports of low levels of fatigue, at diagnosis, in BC survi-
vors predict longer recurrence-free and overall survival
even after adjusting for key clinical and socio-
demographic confounders [9]. Thus, decreasing the bur-
den of PCRF could lead to a positive impact on women’s
quality of life as well as improve their clinical status.
Currently, however, there are few treatment options for
PCRF.
Acupressure is a technique derived from acupuncture,
a component of Traditional Chinese Medicine (TCM).
In acupressure, physical pressure is applied to acupunc-
ture points by the hand, elbow, or with various devices
to treat disease. Acupressure has several advantages over
other potential PCRF treatments: it is self-administered
with little effort and time on the part of the patient; it is
well tolerated; low-cost; and requires minimal instruction
by clinic staff, e.g., nurse. Pilot randomized controlled trials
(RCT) have demonstrated that self-administered acupres-
sure can significantly decrease PCRF by as much as 70%
from baseline levels in cancer survivors [10]. Acupressure
can also have positive effects on sleep quality [11,12] and
sleep quantity [10,12] in cancer patients and other chronic-
ally ill populations, but the degree to which these sleep
improvements influence improvements in PCRF has not
been explored. In a pilot clinical trial, Zick and colleagues
[13] found that relaxation acupressure (RA) reduced PCRF
more than stimulatory acupressure (SA), although PCRF
was reduced by both treatments. In a separate study,
Harris and colleagues [14] showed that sleepiness was
increased to a greater degree following RA compared to
SA. Based on these findings we designed a RCT to inves-
tigate the effect of self-administered acupressure on
PCRF and sleep in a large group of breast cancer survi-
vors. Below is an outline of our study design.
Study aims and hypotheses
The hypothesis of this project is that self-administered RA
will result in improvements in measures of PCRF, quality
of life, and sleep quality, compared to SA and standard of
care. To assess this hypothesis, our primary aim is to
examine the effect of 6-weeks of RA compared to a regi-
men of SA or standard of care on fatigue as assessed by:
A. weekly self-report using the Brief Fatigue Inventory
(BFI), our primary outcome.B. objective daytime physical activity on a wrist worn
accelerometer using average activity counts/minute.
C. fatigue severity assessed 4 times daily using a visual
analog scale recorded on wrist-worn accelerometer.
D. quality of life as assessed by Long Term Quality of
Life Instrument (LTQL).
Our secondary aims include investigating the effect of
6-weeks of RA compared to a regimen of SA or standard
of care on sleep quality of BC survivors as assessed by:
A.monthly self-report using the Pittsburgh Sleep
Quality Index (PSQI), our primary outcome.
B. daily sleep/wake diaries and nighttime actigraphy.
C. examining the relationships between improvements
in sleep quality and improvements in quality of life
for SA and RA, as assessed by LTQL.
Our other secondary aim is to assess activity para-
meters required for implementation of an acupressure
treatment in a clinical setting including the time to onset
of a clinically meaningful effect as well as the duration
of effect following cessation of the intervention. These
factors are currently unknown for acupressure.
Methods/design
Study design
This is a randomized parallel group clinical trial with
three study arms. The study schema and estimated re-
cruitment numbers are presented in Figure 1. The study
was approved by the University of Michigan Medical
School Institutional Review Board and participants pro-
vided written informed consent.
Study participants
The study participants are female breast cancer survivors
(stage 0-IIIa), aged 18 years and older who were at least
12 months post-treatment and had a complaint of per-
sistent, moderate to severe fatigue despite standard
treatments. We detail eligibility criteria along with
source of that material and the study personnel respon-
sible for determining that criteria in Table 1. One of the
principal investigators, who is a physician, reviews all eli-
gibility documents and determines a woman’s suitability
for participating in the study.
Randomization, blinding and allocation concealment
This is a single-blinded study. Participants, investigators,
study nurses and all study staff are blinded. However,
the nurses who teach the acupressure will know if parti-
cipants are assigned to the standard of care arm or one
of the two acupressure arms. The randomization scheme
was created by the study statistician. Within each county
under study, eligible patients are being randomized into
Figure 1 Flow of Participants Through the Study.
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a 1:1:1 ratio for a target total of 375 patients.
Recruitment and enrollment challenges
There are multiple steps to obtaining an adequate sam-
ple size for an RCT consisting of cancer survivors. They
are often no longer in the formal care system and must
be located via alternative means. In the acupressure
study, participants are identified through the Michigan
Tumor Registry (MTR), which is run by the Michigan
Department of Community Health (MDCH). The regis-
try collects information about cancer incidence, stage,
and to a limited extent, the kinds of treatment that
patients receive. These data are reported to the registry
from oncology facilities statewide. The MTR also
includes cancer case information received from the
metropolitan Detroit Surveillance, Epidemiology, and
End Results (SEER) registry. The Michigan Cancer Sur-
veillance Program, which operates the Michigan Tumor
Registry, is a member of the North American Associ-
ation of Central Cancer Registries (NAACCR). The
registry is certified by NAACCR as meeting all standardsfor quality, completeness, timeliness, and unresolved
duplicate records (1 per 1000 tumors) and is estimated
to be greater than 95% complete based on external
audit findings.
The initial step is for the study team was to obtain
Institutional Review Board (IRB) approval from the uni-
versities involved as well as the MTR. Next, the study
team worked collaboratively with the staff at the MTR
to clarify the population of interest. MTR Data were
requested for women diagnosed between January 1st,
2006 and December 31st, 2010, from 5 counties in
Michigan (Wayne, Washtenaw, Ingham, Genesee, and
Kent). These counties represent significant population
centers (Detroit, Ann Arbor, Lansing, Flint, and Grand
Rapids), and areas of racial and ethnic diversity.
The next step in the process of contracting the target
population was by regulation conducted by the MTR.
The State health department is required to make the
first contact according to State regulations, since the
MTR was formed under the auspices of the State’s Pub-
lic Health Authority. Specifically, the MTR first contacts
the physicians who diagnosed and treated the patients in
Table 1 Eligibility Criteria vs. Source Document
Criteria Source Assessor
Female breast cancer survivors Medical Records, Michigan Tumor Registry, Medical
History & Physical Exam
Study Nurse, Study
Coordinator
Cancer free Medical Records, Michigan Tumor Registry, Medical
History & Physical Exam
Study Nurse, Study
Coordinator
Completed treatment (i.e., surgery, chemotherapy, radiotherapy,
immunotherapy, etc.) at least one year prior
Medical Records, Medical History & Physical Exam Study Nurse, Study
Coordinator
Capable of self-administering acupressure Observation at screening visit Study Nurse, Study
Coordinator
Complaint of fatigue Brief Fatigue Inventory score of≥ 4 Study Nurse, Study
Coordinator
Pregnant or planning to become pregnant Pregnancy test, Medical History & Physical Exam Study Nurse, Study
Coordinator
Fatigue causing comorbidities (e.g. anemia, fibromyalgia diagnosis prior
to breast cancer)
Medical Records, Medical History & Physical Exam Study Nurse, Study
Coordinator
Medication changes Review of Concomitant Medications, Medical
History & Physical Exam
Study Nurse, Study
Coordinator
Acupuncture/Acupressure w/in 6 months Communication with potential participant Study Coordinator
Non-Breast cancer diagnosis w/in 10 years Medical History & Physical Exam Study Nurse




Untreated major depressive disorder and suicidal ideations PRIME-MD (‘several days’ indicated on question 2i) Study Nurse, Study
Coordinator
Final, overall eligibility Potential participant’s final review of eligibility Principal Investigator
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explains the purpose of the mailing, asks about any con-
traindications to contacting the patient, and requests
updated contact and vital status information. It includes
a response form with the letter. A passive response ap-
proach is used. This method provides physicians with
MTR fax and phone numbers, and instructions to re-
spond by a specific date, or the MTR will assume no
contraindications to contacting the patient, and that she
is alive and residing at the address provided.
Following the physician contact, the MTR staff noti-
fies eligible women by mail of the opportunity to enroll
in the Acupressure for Persistent Cancer Fatigue Study.
This mailing asks if a member of the research team
may contact them about this research. As with the
mailing to physicians, a response form is included with
the patient letters. The MTR staff also responds to calls
from patients with inquiries. The recruitment project
supervisor at MTR serves as a backup for handling the
most difficult calls. Multiple attempts are made to reach
the women, and up to 3 mailings are sent to BC survi-
vors, with the last letter being sent by certified mail.
Current addresses for mailings that are returned as
undeliverable are tracked using online LexisNexis
services.
The final step to recruitment for the MTR is when
identifiable data is released to the study office on those
women who gave their permission to be contacted about
possible study enrollment.From this point on, the research team approaches the
women referred by the MTR. The research staff contacts
the women (with up to six phone call or email attempts)
to discuss enrollment and screening for the Acupressure
for Persistent Cancer Fatigue Study.
Multilevel screening for eligibility and consent
procedures
Pre-screening
Upon receiving the release of contact information from
the MTR, the interested study candidates are contacted
by the study coordinator. The study coordinator explains
the study to them and also asks the potential participant
a short number of questions to confirm their potential
eligibility and interest in the study.
Visit 1 - screening visit (to determine eligibility)
Once the pre-screening is completed and the study can-
didate appears eligible the study coordinator schedules a
‘screening visit’ with the study nurse in the Michigan
State University (MSU) County Extension office closest
to the potential participant’s home location in the 5
counties in Michigan: Wayne, Washtenaw, Ingham,
Genesee and Kent.
At the screening visit Informed Consent is reviewed,
signed and all questions are answered. A brief physical
exam including vitals is performed. Socio-demographic
information, medical history and a list of current medi-
cations are collected. The study nurse also conducts a
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status. Finally, potential participants complete a short
battery of self-administered paper and pencil question-
naires, which help determine study eligibility (Table 1).
Pre-baseline
The PI reviews the documents and confirms the eligibil-
ity for the study candidate. An Actiwatch-Score (here-
after referred to as Actiwatch-S; Phillips Respironics,
Bend OR), a wrist-worn accelerometer, and a study log
book along with instructions are mailed to them. An
Actiwatch-S is a wristwatch-like device that continuously
measures activity levels and also allows for input of fa-
tigue severity scores. The device is worn by the partici-
pant throughout the study period. The study log book
accompanies the Actiwatch-S and has additional ques-
tions about activity and sleep quality to be completed
within and across days in the study. The participants
enter their fatigue scores in the log book as they do in
the Actiwatch-S, which provides a cross-validation of the
time-stamped fatigue entries. The participants are
instructed to wear the Actiwatch-S for one week prior to
the Baseline Visit and to record their fatigue three times
a day at pre-scheduled times after hearing an audible
alarm. Prior to the Baseline appointment, the participant
is randomized into one of the three arms.
Visit 2- baseline visit (week 0)
At the visit participants fill out questionnaires as indi-
cated in Table 2. If the participants are randomized into
one of the acupressure treatment arms, they are given
acupressure instructions by the study nurse. A DVD, a
handout describing acupressure, and illustrations of the
proposed acupressure points are also given to the parti-
cipants. On this visit the participant returns the
Actiwatch-S and the study logbook. The data from the
Actiwatch-S are downloaded and the watch is reinitia-
lized and given to the participant along with a new log
book.
Visit 3 (week 3)
The participant completes the BFI questionnaire and ad-
verse events, if any, are noted. Participants are tested for
the accuracy of locating their acupoints and the skill of
precisely stimulating the points (acupressure fidelity
measure), as appropriate. Participants return the
Actiwatch-S and the log book. The data from the
Actiwatch-S is downloaded; the watch is re-initialized,
and returned to the participant along with a new study
log book.
Visit 4 (week 6)
Marks the end of doing acupressure and the beginning
of the follow-up phase: Participants complete a batteryof questionnaires, are asked about any adverse events,
assessed for blinding, and tested for acupressure fidelity
(see Table 2). Data from the Actiwatch-S are downloaded
and the reinitialized and a14-day sleep diary is given to
them. If the participant belongs to the acupressure treat-
ment arm of the study they are asked to stop acupres-
sure treatment for the next 4 weeks.
Visit 5 - final (week 10)
Participants complete all questionnaires (Table 2.) and
the 14-day sleep diary, study log book and Actiwatch-S
are collected.
Weekly phone calls (weeks 110)
Participants are contacted once per week to adminis-
ter the BFI questionnaire, ask about any medical con-
cerns, change in medications, and any questions




Below is a list of self-report measures that participants
complete per the schedule in Table 2.
Hospital Anxiety Depression Scale): this 15-item
questionnaire is a widely used instrument to measure
depression and anxiety [15].
Primary Care Evaluation of Mental Disorders (PRIME-
MD): It is a 26-item self-administered questionnaire
that screens for five of the most common groups of
psychiatric disorders in primary care: depression,
anxiety, alcohol, somatoform and eating disorders [16].
Brief Fatigue Inventory: The BFI assesses the severity of
fatigue and the impact of fatigue on daily functioning in
patients with fatigue due to cancer and cancer
treatment [17].
Actiwatch-S to collect fatigue severity: Four times daily
participants indicate on a scale from 0= “No Fatigue” to
10 = “Extremely Fatigued,” their fatigue severity at that
moment. These scores are entered into the Actiwatch-S
upon completion of their acupressure treatment and at
three pre-scheduled times, once in the morning
(9:00 AM), once in the afternoon (3:00 PM) and once
in the evening (9:00 PM).
Long Term Quality of Life Instrument: The LTQL is a
34 items questionnaire that is self-administered for
evaluating functional impairment and the perceived
effect of that impairment on quality of life in breast
cancer survivors [18].
Breast and Surrounding Area Pain Questionnaire:
The BSAPQ is used for measuring pain in the area
of the breast (defined as the breast, armpit, side of the
body, or arm on the operated side) on either the
Table 2 Study Visits
Visit 1 Daily Visit 2 Visit 3 Visit 4 Weekly Phone Calls Visit 5
Screening
(within 60 days of baseline)
Days (−7 to 70) Baseline Week 0 Week 3 Week 6 Week (−1, 1–2, 4–5 & 7–9) Week 10
Laboratory Values 1 X
Medical Exam/History/Socio-demographics X
Urine Pregnancy Test 1 X
PRIME-MD2 X
HADS 2 X X X
BFI 2 X X X X X X
Concomitant Medication & Supplements X
Sleep Diary X X
Group Randomization 3 X
Actiwatch Data Collected X X4 X4 X4 X4
LTQL X X X
BSAPQ 2 X X X X
GSE 2 X X X
BPI2 X X X X
Study Logbook X X X X X
PSQI 2 X X X
VAS for Pain 2 X
Berlin Questionnaire X
Therapy Evaluation Questionnaire X X
Perform Acupressure 5 X X X
Assess Treatment Fidelity – Self efficacy Measure X X
Adverse Events X X X X
Assessment of Blinding X
1 Complete Blood Count; blood for correlative tests, blood for future DNA analysis, Urine pregnancy test as appropriate.
2 HADS =Hospital Anxiety Depression Scale; BFI = Brief Fatigue Inventory; and PSQI = Pittsburgh Sleep Quality Index; LTQL = Long Term Quality of Life Instrument; BSAPQ=Breast and Surrounding Areas Pain
Questionnaire; GSE =General Self Efficacy Scale; BPI = Brief Pain Inventory; VAS for Pain = Visual Analog; PRIME-MD= Primary Care Evaluation of Mental Disorders.
3 Participants are randomized to one of three treatments: Standard of Care; Relaxation Acupressure; or Stimulating Acupressure.
4 Data file downloaded at these visits.
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removed [19].
Brief Pain Inventory: The BPI is used to assess average
clinical pain [20].
General Self-Efficacy Scale: The construct of Perceived
Self-Efficacy reflects an optimistic self-belief that one
can perform a novel or difficult task, or cope
with adversity in various domains of human
functioning [21].
Pittsburgh Sleep Quality Index: The PSQI evaluates
sleep disturbance over the past month. [22]. Sleep
Diary: Sleep diaries are simple, non-invasive, self-report
measures that provide night-to-night information on
sleep pattern, quality, and relevant daytime behavior.
Visual Analog Scale for Pain Severity: The VAS for Pain
will be given at the screening visit. It contains only one
question which asks about overall pain intensity within
a one week period and ranges from no pain up to worst
possible pain. Participants are asked to place a tick
mark along a solid 10 cm line.
Berlin Questionnaire: The Berlin Questionnaire asks
questions to determine the likely presence or absence
of sleep apnea [23].
Therapy Evaluation Questionnaire: The Therapy
Evaluation Questionnaire asks about the subject’s
perception of the treatment on a 7-point scale ranging
from “not at all” up to “very” [24].
Adverse Events: Toxicity are graded according to NCI
Common Toxicity Criteria version 4.02 [25].
Treatment Fidelity and Self-efficacy Measure: The
acupressure educator asks the participant to identify
each of their acupoints and to stimulate 1 point on the
educator. Participants are also asked to record how
long they should stimulate acupoints and how
frequently treatments should be administered.
Assessment of Blinding: At the week 6 visit participants
are asked if they believed they received “the stimulating
acupressure”, “the relaxing acupressure”, or
“don’t know”.
Logbooks: A logbook is used for double data entry and
to verify actigraph data (both movement and recording
when acupressure was performed).Objective study measure
Actiwatch-S is used to collect daytime and nighttime
physical activity and symptoms
This wrist-worn accelerometer monitors the occurrence
and degree of motion and measures the number of
movements that exceed 0.01 g gravitation force. Activity
data are downloaded to computer and sleep/wake activ-
ity is estimated using ActiwareW – Sleep software. It is
important to emphasize that actigraphy does not mea-
sure sleep per se, but a behavior that is highly correlatedwith sleep—level of activity. Sleep episodes, both intended
and unintended, can be reliably identified when low
activity occurs in the presence of other indicators of
sleep, such as self-reported sleep [26-29]. Participants
are instructed to wear the Actiwatch-S at all times. If the
Actiwatch-S is removed, removal and replacement times
are recorded in a daily log book. The software uses a
validated algorithm to compute standard parameters of
sleep/wake and activity cycles for each day of recording,
which are checked by our study staff using the log
books. The primary outcomes for nighttime actigraphy
are total sleep time (total minutes scored as sleep by the
ActiwareW algorithm) and sleep efficiency (total sleep
time/time in bed*100,%).
Actigraphy has also more recently been used by
members of our research team to examine daytime
physical activity by measuring activity patterns [28-32],
the effects of a physical activity intervention [30], and
to assess fatigue. The assessment of fatigue using this
method improves upon existing recall-based methods of
symptom reporting in which people tend to underre-
port or report only peak or recent symptoms [33]
Figure 2.Acupressure intervention
The study utilizes individual instruction by acupressure
educators to teach study participants about the acupres-
sure intervention. Acupressure educators are local study
staff (located in the county where the women are being
recruited from the cancer registry) made up of nurses
who have been trained by one of the study co-principal
investigator (Co-PI), who is a professional acupuncture
practitioner. The study Co-PI meets with the local acu-
pressure educators for an initial training session. At this
session he explains the basic philosophy of TCM and
acupressure, demonstrates both sets of study acupres-
sure points on himself and on the educator. He also
gives the educators a DVD of a person performing the
acupoints, laminated illustration of acupoints along with
a written description of where the points are located. He
also asks the educators to demonstrate the correct loca-
tion of the acupoints on themselves as well as proper
pressure and stimulation techniques.
The Co-PI makes a site visit to observe the acupres-
sure educator performing both sets of acupoints (stimu-
lating and relaxing) on themselves. He notes how many
acupoints are correctly located and makes any needed
corrections. He also asks them to apply the correct
amount of pressure and stimulation on a point on him.
The Co-PI has a checklist that interveners must match
at a 95% rate. After the acupressure educator has en-
rolled two participants, the Co-PI returns to the site to
check for the efficacy of the acupressure educators
Figure 2 Representation of an Actigraph.
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the acupressure educators are how we measure their
treatment fidelity. Acupressure educators can request
additional clarification and instruction as needed.
From our previous study, participants can be taught to
perform their acupoints within 15 minutes [13]. Acu-
pressure educators meet with each participant separately
and demonstrate the location of each acupoints on
themselves and on the participants. Participants also
have the acupoints marked on them with adhesive
colored dots to reinforce the location of the acupoints
for the first few days. At the end of the session partici-
pants are asked to demonstrate the location of all their
acupoints to the educator and appropriate adjustments
are made.
Acupressure educators also demonstrate on the par-
ticipant the appropriate level of pressure to apply on the
acupoints and the correct stimulating motion. Partici-
pants are then asked to stimulate points on the educator
until it is determined that they are using the correct
pressure and stimulation. Participants are told and givena handout with the following information for correctly
performing their acupressure:
“Once you have identified the pressure point location,
use the pad- not the tip- of your index finger to apply
pressure. Place your index finger on the selected point
and turn it in a clockwise direction. Apply firm
pressure to the point using a light to moderate touch
depending on your sensitivity. The points may feel
somewhat tender to the touch, and pressure should be
enough to illicit that sensation. There should be a
distinct feeling around or at the site of pressure. This
may be felt as numbness, warmth, tingling, aching or
buzzing sensation. If no sensation is felt, try applying
more pressure. Please note that some points are more
sensitive than others, and in fact you may not feel any
sensation at certain points.
Pressure should be applied for 3minutes per point.
Treatments are done every day, once per day.
Pressure points should be done in the order
provided, starting from the head down to the feet.
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located on both sides of the body, apply pressure to
the RIGHT side, followed by the LEFT side prior to
proceeding to the following point.
Do NOT lose contact with the point. If you need to,
you may take a break in between points for a couple
of minutes. Please do NOT take a break in the middle
of applying pressure to a point.
Acupressure can be performed sitting, standing or
lying down.”
Participants may return at any time to be retrained or
ask clarifying questions.
Acupoints were chosen by consensus of four acu-
pressure practitioners and based on a previous study
design in students with sleep disturbances as well as
TCM theory for treating insomnia and fatigue. Practi-
tioners had all been in practice for at least 2 years ac-
tively seeing patients. They also had been trained as
and received one of more of the following degrees; a
Naturopathic Doctorate (ND), masters in TCM or
Oriental Medicine and a license of acupuncture (L.Ac.)
or a diploma in acupuncture (Dipl. Ac.). Practitioners
were asked to choose a set of relaxing and stimulating
acupressure points based on a Western diagnosis ofFigure 3 Acupressure Point Locations.fatigue that could be reasonably reached by partici-
pants, i.e., not the middle of the back, and not so
many points that it would take an excessive amount of
time to complete a treatment. Following is a descrip-
tion of the two acupressure treatments and the defin-
ition of standard of care:
Relaxation acupressure
In addition to standard of care participants are asked to
apply pressure on each of following points (bilaterally
where indicated). There are five acupoints with four of
the acupoints performed on both the left and the right
sides of the body giving a total of nine points to stimu-
late. Each of the nine acupoints is stimulated for three
minutes per point giving a total treatment time of
27 minutes done once daily. The acupoints are:
Yin tang (Unilaterally), Anmian (Right and Left/
bilaterally), Heart 7 (HT7) (Right and Left/bilaterally),
Spleen 6 (SP6) (Right and Left/bilaterally), Liver 3
(LIV3) (Right and Left/bilaterally).
Stimulating acupressure
In addition to standard of care participants are asked to
apply pressure on each of following points (bilaterally
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the acupoints performed on both the left and the right
sides of the body giving a total of ten points to stimulate.
Each of the ten acupoints is stimulated for three minutes
per point giving a total treatment time of 30 minutes
done once daily. The acupoints are:
Du 20 (Unilaterally), Conception Vessel 6 (CV6),
Large Intestine 4 (LI4) (Right and Left/bilaterally),
Stomach 36 (ST36) (Right and Left/bilaterally),
Spleen 6 (SP6) (Right and Left/bilaterally), Kidney 3
(K3) (Right and Left/bilaterally).
Locations of the acupoints can be found in Figure 3.
Standard of care
Participants are asked to continue doing whatever their
healthcare providers advise for PCRF. We anticipate that
most women will be treated per the National Compre-
hensive Cancer Network (NCCN) Clinical Guidelines for
Fatigue V1.2009 (NCCN Guideline for fatigue) [34].
These guidelines recommend stress management or cog-
nitive behavioral therapy; short naps and possible use of
stimulants and sleep medications. Participants will be
asked to continue any current treatment and not to start
or stop treatments over the course of the study. All
treatments for fatigue will be recorded.
Statistical issues
Statistics and power analysis
Primary Aim: The primary aim of this study is to investi-
gate the differential effects of different modes of acu-
pressure on fatigue in breast cancer survivors. For this,
we are focusing on three fatigue outcomes, namely, BFI,
which will be administered weekly, a measure of average
daily physical activity and a self-reported fatigue score,
both based on Actiwatch-S data. A BFI is collected
weekly and provides a measure of average degree of fa-
tigue, a score that ranges between 0 and 10, with higher
numbers indicating more fatigue. We will be analyzing
the BFI outcome over phases. The first phase BFI is
obtained by averaging week-1 to week-3 measures (mid-
treatment). The second phase comprising of week-4 to
week-6 measures indicates the status in the second half
of the treatment phase (end-treatment). The final phase
comprises of week-7 to week-10, the washout phase
(washout). In order to investigate the change in BFI be-
tween the three study arms, we are using a mixed-effects
regression analysis with average BFI in the three phases
as the outcome, phase as the within-subjects factor, and
group (RA, SA, standard of care) as the primary
between-subjects factor. The baseline BFI level will be
used as a covariate. We shall further adjust the modelfor key demographic variables such as age and ethnicity,
as well as the baseline HADS score. A subject random-
effect will be used to account for the clustering effect
within the three measurements on the same subject. Of
primary interest is the group*phase interaction, the sig-
nificance of which will indicate differences in extent of
decrease between the arms. Post-hoc analyses of phase
difference within each arm will be carried out multiple
comparison adjustment. Model diagnostics will be car-
ried out to confirm the distributional assumptions and
appropriate corrective actions (e.g. transformation) will
be performed as needed.
Two types of fatigue-related measures will be collected
from the Actiwatch-S. The first is a daytime activity
count per minute, which is calculated by dividing the
total daily activity counts by the total daytime minutes.
For each phase as defined above, we shall use the corre-
sponding 21-day (or 28-day) average as appropriate. The
second type of measure is obtained from the four self-
reported readings of the VAS-F. The daily averages are
obtained from the non-missing entries each day, and are
then combined to provide the phase average the
same way as the daytime activity count. The analytical
framework is identical to that for BFI, albeit with the
changed outcome.
A secondary analysis with BFI will also be carried out
which investigates the difference in proportion of se-
verely fatigued subjects (BFI ≥ 6) across the three study
arms. The analytical framework will be that of a mixed-
effects logistic regression model with severe BFI (yes/no)
being the dichotomous outcome. Apart from group,
phase, and group*phase interaction as primary covari-
ates, the model will also be adjusted for baseline status
of severity. Remaining covariates in the model are identi-
cal to those in the continuous BFI model. The clustering
effect due to subject will be accounted for using a gener-
alized estimating equations approach.
In order to assess the extent of association between
the improvement in FACT-B and improvement in fa-
tigue measure (specific aim #1 letter D), we shall create
the change-scores (week 6 – baseline, week 10 – base-
line) for FACT-B (both total and component scores),
and BFI. Then we shall fit a linear mixed model similar
to that for the original BFI analysis, with BFI change-
score as outcome, and the FACT-B change-score as a
time-varying covariate. There will not be any phase or
week variable in the model. We shall restrict this ana-
lysis to the SA and RA arms only so that the group vari-
able will consist of two levels. A group*FACT-B
interaction in the model will investigate any differential
association across the arms between the change-scores.
The additional covariates and clustering adjustment
would be similar to the BFI analysis.
Secondary Aims:
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to sleep parameters
One of the most widely used sleep measures is the
PSQI, which shall be administered at baseline, week 6
and week 10. We shall follow the scoring convention
followed for PSQI which constructs scores for seven
components, namely sleep quality; sleep latency;
sleep duration; habitual sleep efficiency; sleep
disturbances; use of sleep-promoting medication; and
daytime dysfunction, all derived from the original
PSQI. The component scores are summed to obtain
a total score, the primary outcome for the proposed
study. The modeling framework and subsequent
analysis will be similar to that for BFI with the phase
variable replaced by a continuous week variable. A
logistic regression analysis will be carried out with a
dichotomous outcome indicating whether PSQI > 7
or not since the threshold of 7 is considered an
indicator for sleep quality in BC survivors. A number
of secondary sleep outcomes will be obtained using a
conjunction of the Actiwatch-S-S data and sleep
diary. These will include measures of total sleep time
(minutes spent asleep each night) and sleep efficiency
(total sleep time/time in bed* 100). These can all be
analyzed using the models and methods described
above within the mixed linear or logistic regression
modeling framework as appropriate.
2. Assessing differences in time to onset and time to
relapse (after treatment ends) across the
acupressure arms
Time to onset of the acupressure effect will be
investigated by studying the treatment subgroups,
namely RA and SA. For fatigue, we shall use the daily
average values of VAS-F. Time to onset will be
calculated as the first time (in days) the VAS falls
down by 3 points in comparison to the baseline. We
shall restrict this analyses to subjects whose baseline
VAS-F is at least 3. A proportional hazards
regression model will be employed to analyze the
time to onset data. Treatment arm (RA vs. SA) will
be used as the primary covariate in the analysis.
Independent variables used in the earlier regression
analyses for the primary and secondary aim 1 will be
used as additional covariates.
For sleep, we shall use the VAS-SQ measure to carry
out our time to onset analysis. As in the case of fatigue,
a 3-point drop from baseline in VAS-SQ for the first
time will be considered as onset. Since the VAS-SQ mea-
sures are weekly, we shall employ a discrete survival
analysis technique to analyze this data. A discrete
survival model is a logistic regression model of the
discrete-time hazards, and is easily implemented in most
standard statistical softwares. As in the case for VAS-F,this analysis will be confined to subjects with a baseline
VAS-SQ score of 3 or more.
We would analyze similarly the time to relapse since
the end of treatment, which is defined as the first time a
3-point increase (VAS-F or VAS-SQ) from the six-week
value, occurs. This part of the analysis will be restricted
to subjects for whom an onset has occurred.
All statistical analyses will be carried out in SAS 9.3
and PASW version 19.
Power analysis
Our power analysis is based on our primary aim of com-
paring fatigue as measured by BFI across the three study
arms.
We compute the power via simulation using a mixed
effects model with a between-subject factor group (3
levels), a within-subject factor phase (2 levels), group*-
phase interaction and a random subject effect. The mean
BFI values at mid-treatment were assumed to be 4, 3, 3,
respectively for standard care, SA and RA arms whereas
the means were taken to be 4, 3, 2 at the end-treatment
point in the same arms. The between-subject variance is
assumed to be 4 at all time-points whereas the variance
of the random subject component is taken to be 4 also
(yielding an intra-class correlation of 0.5). These assumed
values are estimates based on our pilot data. For this
configuration, the power for detecting the difference
between groups is more than 0.95 and the power for
detecting a significant phase*group interaction is 0.82
with a sample size of 100 per treatment arm and a 5%
level of significance. In the second model discussed in
the analysis section with phase comprising of end-
treatment and washout, if we assume the washout point
BFI values to be 5, 4, 3, in the standard care, SA, and RA
arms, respectively, the power for detecting either the
phase effect or group effect are both around 99%.
We also have powered the study to allow us to observe
differences in sleep parameters. The extent of overlap
between fatigue and sleep disturbances in BC survivors
is currently unknown. Research indicates that 51% of BC
survivors experience sleep disruptions and 19% meet
diagnostic criteria for insomnia [35]. While fatigued
women are most likely enriched with individuals experi-
encing sleep disturbances we will conservatively assume
that roughly 51% women will have some significant sleep
disturbances and 19% will have insomnia per treatment
arm. As such, with 100 women per treatment group we
will be overpowered for detecting a difference in fatigue
and sufficiently powered to detect changes in key sleep
measures. For example, using the PSQI as a basis for
powering differences in sleep quality from previous stud-
ies the mean PSQI in BC patients ranges from
6.84 ± 0.376 to 7.16 ± 0.325.(60,74) A 1 point decrease in
the PSQI from ~7 to ~6 is considered clinically
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values at mid-treatment are assumed to be 7, 6, 6, re-
spectively in standard care, SA and RA arms whereas
the means are taken to be 7, 6, 5 at the end-treatment
point in the same arms. Assuming an intra-subject cor-
relation of 0.5, we have powers above 99% to detect any
of the group, phase, and group*phase interaction effects
with a sample size of 100 per treatment arm and a 5%
level of significance.
All power calculations are carried out on the basis of
100 simulations in the software PASS 2008 (NCSS, Kays-
ville, Utah, USA).
Data safety monitoring plan (DSMP)
The PIs review study progress weekly with study staff,
and problems with or pertaining to study subjects are be
communicated immediately. The entire research team
meets monthly to review progress and any problems
encountered. This team includes one physician, a PhD
trained nurse and trained acupuncturist who are highly
experienced with cancer control trials. The PIs are noti-
fied when an AE occurs and determine the attribution
and relatedness of each adverse event. All AEs must be
given to the PI within 48 hours if involving a death or
life threatening event, or within one week, if serious
(not-life threatening/death) or non-serious. Lastly, we
work with the UM Prevention Research Base DSMB
which meets monthly by means of regularly scheduled
meetings.
Composition of the UM Prevention Research Base
DSMB: the PI is present in an open session portion of
the meeting and absent in a closed session. All DSMB
official subjects in the review of confidential data and
discussions regarding continuance or stoppage of a
study have no conflict of interest and no financial stake
in the research outcome. The current UM Prevention
research base Data and Safety Monitoring Committee is
Chaired by the Dr. Mack Ruffin and comprised of Fac-
ulty members from the departments of gastroenter-
ology, Family Medicine and Hematology/Oncology. At
least 3 faculty members, not including the study PI,
must be present to have quorum. If the DSMB cannot
meet face-to-face, a conference call is acceptable. Prior
to each meeting, the UM Prevention Research Base
clinical research associate distributes a standard sum-
mary report detailing accrual, new publications or pre-
sentations relevant to the ongoing project, quality
control audit information, any ethical concerns, patient-
subject complaints and adverse events or serious ad-
verse events.
Our study was initially reviewed by The UM Prevention
Research Base DSMB beginning in the second year from
initial funding and monthly after that. The DSMB also
reports its findings of any adverse events or decisionsregarding modification of the protocol to the University
of Michigan IRB committee.
Discussion
This clinical trial will help to determine the efficacy and
acceptance of a self-administered acupressure technique
in BC survivors for PCRF. In order to answer this ques-
tion, we have developed a protocol and study design
with numerous unique aspects. One unique study design
is utilizing nurses to teach acupressure to participants. If
nurses can successfully learn and teach participants how
to administer acupressure it may demonstrate the possi-
bility to teach nurses acupressure in “real world” settings
such as Family Medicine practices. Another unique as-
pect of this study is the use of two sets of acupressure
points that are hypothesized to work in an opposing
fashion. Two of our pilot studies demonstrated that by
using opposing acupoints (stimulating and relaxing) we
saw statistically significant differences between treatment
groups [13,14]. This effect remains consistent despite
using the design in two distinct samples (students and
cancer survivors) and while examining different out-
comes (fatigue severity and sleepiness). Many previous
acupressure studies using various types of sham or con-
trol acupressure and or acupuncture find no difference
between sham and active treatment, although normally
both treatment arms are better than standard of care.
This has led some to theorize that acupressure and acu-
puncture effects are non-specific and should be viewed
as placebo only. Others propose that all acupoints or
perhaps all places on the body act in identical fashion
when stimulated making it unimportant what points are
chosen for treatment and rendering the concept of con-
trol/sham acupoints meaningless. Researchers struggle
with these challenges in an attempt to demonstrate spe-
cific effects for various acupuncture treatments. Our re-
search design appears to address this challenge of
showing a significant difference between treatment arms
and showing a specific effect for a given set of acupoints.
One other unique point of this trial is the deconstruc-
tion of the study intervention. In particular, we are
examining how long it will take for acupressure to have
an effect on a given outcome by collecting weekly, and
in the case of fatigue severity, daily information. In the
case of fatigue measures we are also observing if acu-
pressure works through steady cumulative changes or
through sudden dynamic effects. Moreover, we are able
to observe if different sets of acupoints create different
patterns. Very few studies have attempted to assess these
effects of acupuncture or acupressure treatments. This
has led some researchers to posit that negative findings
in acupressure and acupuncture studies could be due
to false negative results from too few total number of
treatments, inappropriate frequency of treatments and
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support the idea that fewer sessions per week or short
length of acupuncture treatment are not as effective at
decreasing pain. Harris and colleagues [14] found that 3
acupuncture sessions weekly provided more pain relief
than 1 session weekly (p = 0.039). Another research
group [36] discovered that the difference between sham
and true acupuncture for pain was not evident at 8 weeks
but was statistically significant at 14 weeks. Our study
will help to clarify issues of how long and the pattern of
change needed for change in the study outcomes.
Our protocol also has several distinctive aspects in-
cluding that cancer survivors are often only seen by their
oncologist once a year, or not at all, depending on the
number of years from diagnosis. Instead they often
obtaining health care from a variety of medical specialist
including, but not limited to, family medicine, internal
medicine, and gynecology. Cancer survivors are also
spread over large geographic areas leading them to seek
health care in a wide variety of locations including pri-
vate clinics, community hospitals and large health sys-
tems. These characteristics of cancer survivors are
barriers to traditional recruitment methods where
patients in a clinic are approached for potential study
participation. To overcome these challenges we have
incorporated several unique designs into our study. First,
to identify and recruit participants we work with the
Michigan Tumor Registry. As the tumor registry con-
tains more than 95% of all of the cancer cases in Mich-
igan we are able to bypass clinic recruitment instead
opting for mailings to all potential breast cancer survi-
vors within a certain county and date of diagnosis. Also,
our protocol makes use of the MSU County Extension
offices within several Michigan Counties to conduct
study visits. By locating our screening and future study
visits in the same county as we are recruiting we
minimize travel distances for participants, while maxi-
mizing the area from which we can recruit for the study.
The MSU County Extension offices provide locations by
county throughout all 50 States. As such, they provide
one model in which to conduct multi-site studies with
populations such as cancer survivors who are utilizing
providers in a wide range of specialties or not seeing
health care providers.
Along with numerous strengths our study also has sev-
eral limitations including inability to double blind the
study and lack of an objective measure of fatigue. Cur-
rently, there are no biomarkers for measuring fatigue.
Consequently, fatigue is measured using subjective ques-
tionnaires only. While fatigue is a subjective experience,
the presence of high amounts of variability between and
within participants’ fatigue, over even a short time frame
of a day, argue the benefit of pairing objective measures
of fatigue with subjective questionnaires. We haveincluded the objective measurement of physical activity
and sleep measures using actigraphy. While actigraphy
data does not give an objective measure of fatigue it
does give insights into the effect of fatigue on daily activ-
ity and sleep. Another limitation is our inability to
double-blind the participants as to study assignment.
Data from our pilot study [13] demonstrated that parti-
cipants were blinded as to the acupressure treatment to
which they were randomized. However, this is not the
case between women in this study who are randomized
to one of the two acupressure arms and the standard of
care arm. Despite this limitation, it is an important study
design to be able to compare acupressure treatment to
standard of care for fatigue in these women. By having
this comparison we will be able to have a preliminary
idea about the comparative effectiveness of acupressure
compared to standard of care and have a clearer idea of
what is the placebo versus the real effect of acupressure
treatment.
In summary, this is a protocol examining two oppos-
ing types of self-administered acupressure (stimulating
and relaxing) compared to standard of care for PCRF in
300 BC survivors. This protocol has many strengths
compared to the traditional randomized, double-blind
design. In particular, it utilizes local community
resources in the form of MSU County Extension
Services for study visits, population-based recruiting via
the MTR, and nurses to teach the acupressure inter-
vention. This study is scheduled to be completed
with recruitment in the Winter of 2014 with published
results in 2015.
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